How to determine entrapment efficiency in lipid and polymeric nanoparticles: a methodological guide

• Definition of critical aspects in the determination of drug load/entrapment efficiency • Review of the available separation and drug quantification methodologies • Case studies on NLC and chitosan PNP illustrate development process • Guidance in drug load/entrapment efficiency method development in form of a decision tree In nanomedicine, accurately determining the entrapment efficiency (EE) and drug load (DL) of nanoparticles (NPs) is crucial for assessing their efficacy. EE represents the amount of drug encapsulated within the particles relative to the total drug used during manufacturing. Various methods, both direct and indirect, are employed for EE determination, each with its advantages and challenges. Separation techniques such as (ultra-)centrifugation, ultrafiltration, dialysis, and size exclusion chromatography are commonly used for isolating NPs from the suspension medium. Additionally, direct determination methods like high-performance liquid chromatography and UV/Vis spectroscopy may offer precise quantification of drug content within the particles. Lipid and polymeric NPs pose distinct challenges in EE determination, requiring careful consideration of factors such as solubility, stability, and particle density. Drawing attention to critical challenges and method validation, this work addresses the specific characteristics and methodological considerations for lipid and polymeric NPs. Through a comparative analysis of commonly used techniques, it underscores the importance of method validation and the need for standardised protocols. A decision tree in evidence-based selection of an EE methodology is proposed. In essence, this article serves as a comprehensive guide for scientists in the field of nanoparticle-based drug delivery, elucidating key considerations in formulation development, methodological approaches, and critical challenges for ensuring reproducibility and reliability in NP-based therapeutics.

Authors

Institutions

Publication Details

Journal
OpenNano
Published
2026-04-06
DOI
https://doi.org/10.1016/j.onano.2026.100302
Primary Topic
Advancements in Transdermal Drug Delivery
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

How to determine entrapment efficiency in lipid and polymeric nanoparticles: a methodological guide

Lena Valentin, Regina Scherließ, Niklas Baltz
OpenNano
Advancements in Transdermal Drug Delivery
article

How to determine entrapment efficiency in lipid and polymeric nanoparticles: a methodological guide

Lena Valentin, Regina Scherließ, Niklas Baltz
article en

Abstract

• Definition of critical aspects in the determination of drug load/entrapment efficiency • Review of the available separation and drug quantification methodologies • Case studies on NLC and chitosan PNP illustrate development process • Guidance in drug load/entrapment efficiency method development in form of a decision tree In nanomedicine, accurately determining the entrapment efficiency (EE) and drug load (DL) of nanoparticles (NPs) is crucial for assessing their efficacy. EE represents the amount of drug encapsulated within the particles relative to the total drug used during manufacturing. Various methods, both direct and indirect, are employed for EE determination, each with its advantages and challenges. Separation techniques such as (ultra-)centrifugation, ultrafiltration, dialysis, and size exclusion chromatography are commonly used for isolating NPs from the suspension medium. Additionally, direct determination methods like high-performance liquid chromatography and UV/Vis spectroscopy may offer precise quantification of drug content within the particles. Lipid and polymeric NPs pose distinct challenges in EE determination, requiring careful consideration of factors such as solubility, stability, and particle density. Drawing attention to critical challenges and method validation, this work addresses the specific characteristics and methodological considerations for lipid and polymeric NPs. Through a comparative analysis of commonly used techniques, it underscores the importance of method validation and the need for standardised protocols. A decision tree in evidence-based selection of an EE methodology is proposed. In essence, this article serves as a comprehensive guide for scientists in the field of nanoparticle-based drug delivery, elucidating key considerations in formulation development, methodological approaches, and critical challenges for ensuring reproducibility and reliability in NP-based therapeutics.

OpenNanoVol. 29
Hochschule für Angewandte Wissenschaften Kiel (DE), Christian-Albrechts-Universität zu Kiel (DE)
Affordable and clean energy
Openalex Percentile: Top 23%
Advancements in Transdermal Drug Delivery
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.